RNS Number : 6180Y
Yellow Cake PLC
07 September 2022
 

7 September 2022

YellowCake_Logo_OL.png

 

Yellow Cake plc ("Yellow Cake" or the "Company")

Results of 2022 Annual General Meeting

 

Yellow Cake, a specialist company operating in the uranium sector holding physical uranium ("U3O8") for the long term, is pleased to announce that at the Annual General Meeting of the Company held on 7 September 2022 ("AGM" or the "Meeting") all resolutions were duly passed. Resolutions 1-11 were passed as ordinary resolutions and resolutions 12 and 13 were passed as special resolutions.

The full text of the resolutions passed at the Meeting can be found in the Notice of Annual General Meeting, which is available on the Company's website at www.yellowcakeplc.com. 

The following table shows the votes cast on each resolution:

 

 

 

VOTES FOR

%

VOTES AGAINST

%

TOTAL VOTES VALIDLY CAST

% OF SHARE CAPITAL WITH VOTING RIGHTS

VOTES WITHHELD

1

Annual Report and Accounts

83,009,186

100.00

0

0

83,009,186

45.33

125,370

2

Re-appoint Anthony Tudor St John, The Lord St John of Bletso

75,248,721

90.52

7,880,269

9.48

83,128,990

45.40

5,566

3

Re-appoint Andre Liebenberg

82,975,435

99.82

151,833

0.18

83,127,268

45.40

7,288

4

Re-appoint Carole Whittall

82,981,769

99.82

147,500

0.18

83,129,269

45.40

5,287

5

Re-appoint Sofia Bianchi

82,058,929

98.71

1,070,340

1.29

83,129,269

45.40

5,287

6

Re-appoint Alexander Downer

82,057,204

98.71

1,073,178

1.29

83,130,382

45.40

4,174

7

Re-appoint Alan Rule

82,056,925

98.71

1,072,065

1.29

83,128,990

45.40

5,566

8

Re-appoint Emily Manning

81,825,568

98.44

1,300,837

1.56

83,126,405

45.40

8,151

9

Re-appoint auditor

83,097,034

99.96

31,564

0.04

83,128,598

45.40

5,958

10

Auditor's remuneration

83,129,292

99.99

291

0.01

83,129,583

45.40

4,973

11

Authority to allot shares

71,657,809

86.21

11,462,542

13.79

83,120,351

45.40

14,205

12

Disapply pre-emption rights

82,209,320

98.90

916,831

1.10

83,126,151

45.40

8,405

13

Authority to purchase own shares

82,991,003

99.99

2,618

0.01

82,993,621

45.33

140,935

 

Notes:

(1)        A vote withheld is not a vote in law and is not counted in the calculation of votes for or against a resolution.

(2)        As at close of business on 22 July 2022, being the date used to determine the entitlement of shareholders to attend and vote at the General Meeting, the Company's issued share capital was 187,740,730 Ordinary Shares, the number of Ordinary Shares held in treasury was 4,636,331 and the total voting rights in the Company were therefore 183,104,339.



 

ENQUIRIES: 

 

Yellow Cake plc



Andre Liebenberg, CEO

Carole Whittall, CFO


Tel: +44 (0) 153 488 5200



Nominated Adviser and Joint Broker: Canaccord Genuity Limited


Henry Fitzgerald-O'Connor

James Asensio


Gordon Hamilton

Tel: +44 (0) 207 523 8000




Joint Broker: Berenberg


Matthew Armitt

Jennifer Lee


Detlir Elezi



Tel: +44 (0) 203 207 7800



Financial Adviser: Bacchus Capital Advisers

Peter Bacchus

Richard Allan

Tel: +44 (0) 203 848 1640


Investor Relations: Powerscourt



Peter Ogden

Molly Melville


Tel: +44 (0) 7793 858 211



 

ABOUT YELLOW CAKE

Yellow Cake is a London-quoted company, headquartered in Jersey, which offers exposure to the uranium spot price. This is achieved through its strategy of buying and holding physical triuranium octoxide ("U3O8"). It may also seek to add value through other uranium related activities. Yellow Cake seeks to generate returns for shareholders through the appreciation of the value of its holding of U3O8 and its other uranium related activities in a rising uranium price environment. The business is differentiated from its peers by its ten-year Framework Agreement for the supply of U3O8 with Kazatomprom, the world's largest uranium producer. Yellow Cake currently holds 18.81 million pounds of U3O8, all of which is held in storage in Canada and France. 

 

FORWARD LOOKING STATEMENTS

Certain statements contained herein are forward looking statements and are based on current expectations, estimates and projections about the potential returns of the Company and the industry and markets in which the Company will operate, the Directors' beliefs and assumptions made by the Directors. Words such as "expects", "anticipates", "should", "intends", "plans", "believes", "seeks", "estimates", "projects", "pipeline", "aims", "may", "targets", "would", "could" and variations of such words and similar expressions are intended to identify such forward looking statements and expectations. These statements are not guarantees of future performance or the ability to identify and consummate investments and involve certain risks, uncertainties and assumptions that are difficult to predict, qualify or quantify. Therefore, actual outcomes and results may differ materially from what is expressed in such forward looking statements or expectations. Among the factors that could cause actual results to differ materially are: uranium price volatility, difficulty in sourcing opportunities to buy or sell U3O8, foreign exchange rates, changes in political and economic conditions, competition from other energy sources, nuclear accident, loss of key personnel or termination of the services agreement with 308 Services Limited, changes in the legal or regulatory environment, insolvency of counterparties to the Company's material contracts or breach of such material contracts by such counterparties. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward looking statements contained herein to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based unless required to do so by applicable law or the AIM Rules.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFFIASIDIIF